Michael Rice - 07 Mar 2022 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Reporting relationship: CEO, Director
Issuer ticker: BLFS
Reported as of: 07 Mar 2022
Net transaction value: -$438,100
SEC form: 4
Accepted by SEC: 09 Mar 2022, 20:29:15 UTC
Prior SEC filing: 03 Mar 2022
Next SEC filing: 31 Mar 2022
Source filing: View source filing
Reporting owner signature: /s/ Michael Rice

Key filing fact

Michael Rice filed Form 4 for BIOLIFE SOLUTIONS INC (BLFS) on 09 Mar 2022.

Key facts

This page summarizes Michael Rice's Form 4 filing for BIOLIFE SOLUTIONS INC (BLFS).
6 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 09 Mar 2022, 20:29.

Change

Previous filing in this sequence was filed on 03 Mar 2022.
Current net transaction value: -$438,100.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BLFS transaction

Common Stock

Options Exercise

Transaction value: $19,000
Shares: +10,000
Change %: +3%
Price: $1.90^*
Shares after: 337,985
Date: 07 Mar 2022
Ownership: Direct

BLFS transaction

Common Stock

Sale

Transaction value: $238,000
Shares: -10,000
Change %: -3%
Price: $23.80
Shares after: 327,985
Date: 07 Mar 2022
Ownership: Direct
Footnotes: F1, F2

BLFS transaction

Common Stock

Options Exercise

Transaction value: $19,000
Shares: +10,000
Change %: +3%
Price: $1.90^*
Shares after: 337,985
Date: 09 Mar 2022
Ownership: Direct

BLFS transaction

Common Stock

Sale

Transaction value: $238,100
Shares: -10,000
Change %: -3%
Price: $23.81
Shares after: 327,985
Date: 09 Mar 2022
Ownership: Direct
Footnotes: F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BLFS transaction Derivative

Employee Stock Option

Options Exercise

Transaction value: $0
Shares: -10,000
Change %: -10%
Price: $0.000000
Shares after: 90,000
Date: 07 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,000
Exercise price: $1.90
Footnotes: F4

BLFS transaction Derivative

Employee Stock Option

Options Exercise

Transaction value: $0
Shares: -10,000
Change %: -11%
Price: $0.000000
Shares after: 80,000
Date: 09 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,000
Exercise price: $1.90
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of May 21, 2021.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.57 to $24.14, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.64 to $23.96, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Footnote F4

On March 15, 2016, the reporting person was granted an option to purchase 100,000 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter.